The latest market price and drug purchase reference of inavolisib in 2025

Inavolisib (Inavolisib) is a new type of oral small molecule targeted drug, mainly used for precision treatment of specific cancer patients. The drug interferes with tumor cell proliferation and survival by selectively inhibiting the PI3K α mutation pathway, and has a significant effect on some tumor patients. Due to its clear target, inaliside is clinically regarded as one of the options for precise targeted therapy.

in the country, Inalise has been officially launched but has not yet been included in the medical insurance system. Therefore, patients need to bear all costs when purchasing medicines in the country. Common packaging specifications include 3mg7tablets4boards and 9mg7tablets4boards. The price per box is about 30,000 yuan. Since drugs have been on the market for a short time, prices in pharmacies in different regions may vary slightly. Patients should pay attention to formal channels when purchasing to ensure drug quality.

In overseas markets, the original drug of Inariside is more expensive, with each box selling for more than 200,000 yuan (the price may fluctuate due to exchange rates). Currently, there are no generic versions on the market, so overseas purchases are mainly based on original drugs. If patients need to obtain drugs through overseas channels, they should use formal import channels and use them under the guidance of professional doctors to ensure the safety and efficacy of the drugs.

Overall, inaliset, as a precisely targeted drug, has high clinical value in specific patient groups. There are obvious price differences between domestic and foreign countries. When choosing drug purchasing channels, patients should fully consider their financial affordability, the reliability of drug sources and doctor's guidance, and reasonably arrange treatment plans to maximize drug efficacy and ensure drug safety.

Reference materials:https://www.drugs.com/